JR14a
Product Specifications
CAS Number
2411440-41-8
Target
Complement System
Applications
Immunology & Inflammation
Smiles
CC1=C (SC (=C1) C (C2=CC=C (Cl) C=C2) C3=CC=C (Cl) C=C3) C (=O) NC (CCCNC (N) =N) C (O) =O
Molecular Formula
C25H26Cl2N4O3S
Additionnal Information
JR14a, a selective and potent human Complement C3a receptor antagonist, which is assessed by inhibition of intracellular calcium release (IC50=10 nM) induced in human monocyte-derived macrophages by C3a, inhibition of β-hexosaminidase secretion (IC50=8 nM) from human LAD2 mast cells degranulated by C3a, and selectivity for human C3aR over C5aR.
Storage Conditions
3 years -20°C powder
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1087346 Inquire
Recombinant Yersinia enterocolitica serotype O:8 / biotype 1B ATP synthase subunit c (atpE)
Sign In for Pricing
View Details 
MBS1365833-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus Putative dipeptidase MW1694 (MW1694)
Sign In for Pricing
View Details MBS1365833-02 0.02 mg (Yeast)
Recombinant Staphylococcus aureus Putative dipeptidase MW1694 (MW1694)
Sign In for Pricing
View Details 
MBS1365833-03 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus Putative dipeptidase MW1694 (MW1694)
Sign In for Pricing
View Details 
MBS1365833-04 0.1 mg (Yeast)
Recombinant Staphylococcus aureus Putative dipeptidase MW1694 (MW1694)
Sign In for Pricing
View Details